The cloning and expression of renalase and the preparation of its monoclonal antibody

Journal of Shanghai Jiaotong University (Science)

Volumn 14 E, Issue 3, 2009, Pages 376-379

  Wang, Feng ^a   Wang, Nian Song ^a   Xing, Tao ^b   Cao, Yang ^c   Xiang, Hai Yan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b MACQUARIE UNIVERSITY   (Australia)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Antibody; Expression; Monoclonal; Renalase

Indexed keywords

BALB/C MICE; CLONING AND EXPRESSION; DNA FRAGMENT; EXPRESSION; HUMAN KIDNEY; HUMAN SERUM; MONOCLONAL; PURIFIED PROTEIN; RENALASE; SPECIFIC PRIMERS;

CLONING; MONOCLONAL ANTIBODIES; NUCLEIC ACIDS;

SURFACE PLASMON RESONANCE;

EID: 67649194376     PISSN: 10071172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12204-009-0376-9     Document Type: Article

References (18)

1. Xu J, Li G, Wang P, et al. Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure [J]. J Clin Invest, 2005, 115 (5): 1275-1280.
2. Wang J, Qi S, Cheng W, et al. Identification, expression and tissue distribution of a renalase homologue from mouse [J]. Mol Biol Rep, 2008, 35 (4): 613-620.
3. Xu J, Desir G V. Renalase, a new renal hormone: Its role in health and disease [J]. Curr Opin Nephrol Hypertens, 2007, 16 (4): 373-378.
4. Ghosh S S, Gehr T W B, Sica D A, et al. Renalase regulates blood pressure in salt sensitive Dahl rats [J]. J Am Soc Nephrol, 2006, 17: 208A.
5. Li G, Xu J, Wang P, et al. Catecholamines regulate the activity, secretion, and synthesis of renalase [J]. Circulation, 2008, 117 (10): 1277-1282.
6. Desir G V. Renalase deficiency in chronic kidney disease, and its contribution to hypertension and cardiovascular disease [J]. Curr Opin Nephrol Hypertens, 2008, 17 (2): 181-185.
7. Ghosh S S, Krieg R J, Sica D A, et al. Cardiac hypertrophy in neonatal nephrectomized rats: The role of the sympathetic nervous system [J]. Pediatr Nephrol, 2009, 24 (2): 367-377.
8. Go A S, Lo J C. Epidemiology of non-dialysis-requiring chronic kidney disease and cardiovascular disease [J]. Curr Opin Nephrol Hypertens, 2006, 15 (3): 296-302.
9. Santos S F, Peixoto A J. Hypertension in dialysis [J]. Curr Opin Nephrol Hypertens, 2005, 14 (2): 111-118.
10. Anavekar N S, Mcmurray J J, Velazquez E J, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction [J]. N Engl J Med, 2004, 351 (13): 1285-1295.
11. Go A S, Chertow G M, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization [J]. N Engl J Med, 2004, 351 (13): 1296-1305.
12. Joles J A, Koomans H A. Causes and consequences of increased sympathetic activity in renal disease [J]. Hypertension, 2004, 43 (4): 699-706.
13. Zoccali C, Mallamaci F, Tripepi G, et al. Norepinephrine and concentric hypertrophy in patients with end-stage renal disease [J]. Hypertension, 2002, 40 (1): 41-46.
14. Zoccali C, Mallamaci F, Parlongo S, et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease [J]. Circulation, 2002, 105 (11): 1354-1359.
15. Hausberg M, Kosch M, Harmelink P, et al. Sympathetic nerve activity in end-stage renal disease [J]. Circulation, 2002, 106 (15): 1974-1979.
16. Zhao Q, Fan Z, He J, et al. Renalase gene is a novel susceptibility gene for essential hypertension: A two-stage association study in northern Han Chinese population [J]. J Mol Med, 2007, 85 (8): 877-885.
17. Luft F C. Renalase, a catecholamine-metabolizing hormone from the kidney [J]. Cell Metab, 2005, 1 (6): 358-360.
18. Boomsma F, Tipton K F. Renalase, a catecholamine-metabolising enzyme? [J]. J Neural Transm, 2007, 114 (6): 756-775.